EDN1 and metabolic syndrome: In particular, in MetS, alterations in the levels of leptin, resistin, tumor necrosis factor-α (TNF-α), IL-6, angiotensin II, endothelin-1 (ET-1), and adiponectin lead to endothelial dysfunction and vasoconstriction [25].